| abstract |
Antihypertensive agents selected from the group of Angiotensin II receptor antagonists (especially the compound (S)-N-(l -carboxy-2-methylprop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl) biphenyl-4-yl-methyl] amine (valsartan) of formula (I), Alpha-adrenergic antagonists, Beta-blockers, calcium channel blockers (CCBs) and ACE inhibitors, or of a pharmaceutical salt thereof, can be used for the prevention and treatment of insufficient blood flow and cerebral functional disorders. |